药剂类基因焦点:CYP4F2
Pablo Zubiaur1, Cristina Rodríguez-Antona2,3, Erin C Boone4
1Clinical Pharmacology Department, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid (UAM) and Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa (IP), Madrid, Spain.
药物基因变异联盟 (PharmVar) 现在包括CYP4F2基因的新星等位基因. 这种遗传变异影响药物和维生素代谢,影响华法林剂量和其他药物.
科学领域:
- 药物基因组学 药物基因组学
- 人类遗传学 人类遗传学
- 药物新陈代谢 药物新陈代谢
背景情况:
- CYP4F2基因是多态的,在各种物质的代谢中发挥作用.
- 在CYP4F2的遗传变异影响维生素K的新陈代谢,影响华法林剂量.
- 此外,CYP4F2还会影响像伊马替尼和芬戈利莫德这样的药物的代谢,以及像维生素E这样的内源性化合物的代谢.
研究的目的:
- 为提供CYP4F2遗传变异的全面概述.
- 报告14个新的恒星等位基因 (CYP4F2*4到*17) 的表征.
- 描述PharmVar数据与PharmGKB和CPIC的整合.
主要方法:
- 使用药基因变异联盟 (PharmVar) 作为全球存储库.
- 对CYP4F2.2的新星 (*) 基因组命名编目和特征.
- 描述了PharmGKB和CPIC对PharmVar哈普类型数据的应用.
主要成果:
- 关于CYP4F2遗传变异的全面概述.
- 14个新星等位基因的表征:CYP4F2*4到CYP4F2*17.
- 详细说明PharmGKB和CPIC如何使用PharmVar数据.
结论:
- PharmVar为CYP4F2遗传变异提供了重要的命名体系.
- 了解CYP4F2等位基因对于个性化医学,特别是华法林药物遗传学至关重要.
- 列表的变异及其整合到知识库中支持临床实施.
更多相关视频
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Hepatic Drug Clearance: Role of Transporters
Factors Influencing Drug Absorption: Physicochemical Parameters
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
